Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gil D Rabinovici

Showing results (11-20 of 395) with videos related to

Pageof 40
Sort By:
Neurology|September 25, 2023
From Clinical Trials to Memory Clinics, Tau-PET Visual Reads Can Help Diagnosis and Patient StratificationMaura Malpetti, Gil D Rabinovici
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|January 22, 2014
Amyloid imaging in atypical dementiaRobert Laforce, Gil D Rabinovici
Annals of Neurology|April 8, 2010
Beyond diagnosis: what biomarkers are teaching us about the "bio"logy of Alzheimer diseaseGil D Rabinovici, Erik D Roberson
JAMA Internal Medicine|December 3, 2019
Biomarker-Informed Treatment Decisions in Cognitively Impaired Patients Do Not Apply to Preclinical Alzheimer DiseaseGil D Rabinovici, Maria C Carrillo
JAMA Neurology|May 31, 2022
Rare APOE Missense Variants-Can We Overcome APOE ε4 and Alzheimer Disease Risk?Gil D Rabinovici, Dena B Dubal
JAMA Neurology|November 9, 2020
Rapid Progress Toward Reliable Blood Tests for Alzheimer DiseaseElisabeth H Thijssen, Gil D Rabinovici
JAMA|July 17, 2023
Amyloid-Targeting Monoclonal Antibodies for Alzheimer DiseaseGil D Rabinovici, Renaud La Joie
Neurology|September 6, 2013
Imaging prodromal FTD: seeing the future through PET crystalsGil D Rabinovici, Bradley F Boeve
Nature Medicine|May 17, 2023
Silencing tau to treat early Alzheimer's diseasePeter A Ljubenkov, Gil D Rabinovici
JAMA Neurology|August 2, 2021
Professional Soccer and Dementia Risk-The Ugly Side of the Beautiful GameBreton M Asken, Gil D Rabinovici
Pageof 40

Showing results (11-20 of 395) with videos related to

Sort By:
Pageof 40
Neurology|September 25, 2023
From Clinical Trials to Memory Clinics, Tau-PET Visual Reads Can Help Diagnosis and Patient StratificationMaura Malpetti, Gil D Rabinovici
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|January 22, 2014
Amyloid imaging in atypical dementiaRobert Laforce, Gil D Rabinovici
Annals of Neurology|April 8, 2010
Beyond diagnosis: what biomarkers are teaching us about the "bio"logy of Alzheimer diseaseGil D Rabinovici, Erik D Roberson
JAMA Internal Medicine|December 3, 2019
Biomarker-Informed Treatment Decisions in Cognitively Impaired Patients Do Not Apply to Preclinical Alzheimer DiseaseGil D Rabinovici, Maria C Carrillo
JAMA Neurology|May 31, 2022
Rare APOE Missense Variants-Can We Overcome APOE ε4 and Alzheimer Disease Risk?Gil D Rabinovici, Dena B Dubal
JAMA Neurology|November 9, 2020
Rapid Progress Toward Reliable Blood Tests for Alzheimer DiseaseElisabeth H Thijssen, Gil D Rabinovici
JAMA|July 17, 2023
Amyloid-Targeting Monoclonal Antibodies for Alzheimer DiseaseGil D Rabinovici, Renaud La Joie
Neurology|September 6, 2013
Imaging prodromal FTD: seeing the future through PET crystalsGil D Rabinovici, Bradley F Boeve
Nature Medicine|May 17, 2023
Silencing tau to treat early Alzheimer's diseasePeter A Ljubenkov, Gil D Rabinovici
JAMA Neurology|August 2, 2021
Professional Soccer and Dementia Risk-The Ugly Side of the Beautiful GameBreton M Asken, Gil D Rabinovici
Pageof 40